Literature DB >> 12160278

Inducible nitric oxide synthase expression in pharyngeal squamous cell carcinoma: relation to p53 expression, clinicopathological data, and survival.

Matti J Pukkila1, Jari K Kellokoski, Jukka A Virtaniemi, Eero J Kumpulainen, Risto T Johansson, Pirjo M Halonen, Ari S T Kosunen, Juhani Nuutinen, Veli-Matti Kosma.   

Abstract

OBJECTIVE: To investigate the expression of inducible nitric oxide synthase (iNOS) in oropharyngeal and hypopharyngeal squamous cell carcinoma (SCC) and its relation to p53 expression, histologic differentiation, clinical data, and prognosis. STUDY
DESIGN: A retrospective survey.
METHODS: Primary tumors for analyses were obtained from 118 patients diagnosed with SCC of the oropharynx or hypopharynx between 1975 and 1998 in eastern Finland. Immunohistochemical analysis was used to evaluate the expression of iNOS and p53. The expression pattern of iNOS was related to p53 expression, clinical data, and survival.
RESULTS: High iNOS score was associated significantly with high nuclear p53 expression index (P = .006) and positive cytoplasmic p53 expression (P = .025). The score for iNOS expression was significantly lower in the largest (T4) tumors (P = .043). No association was seen between iNOS score and N or M class, tumor stage, or histologic differentiation. The score for iNOS expression was not related to overall survival.
CONCLUSIONS: The expressions of iNOS and p53 seem to be inter-related in pharyngeal SCC, although the causality remains to be clarified. The expression of iNOS shows no prognostic value in pharyngeal SCC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12160278     DOI: 10.1097/00005537-200206000-00027

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  9 in total

1.  Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2.

Authors:  Esther Lopez-Rivera; Padmini Jayaraman; Falguni Parikh; Michael A Davies; Suhendan Ekmekcioglu; Sudeh Izadmehr; Denái R Milton; Jerry E Chipuk; Elizabeth A Grimm; Yeriel Estrada; Julio Aguirre-Ghiso; Andrew G Sikora
Journal:  Cancer Res       Date:  2014-01-07       Impact factor: 12.701

2.  Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy.

Authors:  Andrew G Sikora; Alexander Gelbard; Michael A Davies; Daisuke Sano; Suhendan Ekmekcioglu; John Kwon; Yared Hailemichael; Padmini Jayaraman; Jeffrey N Myers; Elizabeth A Grimm; Willem W Overwijk
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

3.  NO and COX2: Dual targeting for aggressive cancers.

Authors:  Daniel Davila-Gonzalez; Jenny C Chang; Timothy R Billiar
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-13       Impact factor: 11.205

4.  Expression of nitric oxide synthase in human gastric carcinoma and its relation to p53, PCNA.

Authors:  Yong-Zhong Wang; You-Qing Cao; Jian-Nong Wu; Miao Chen; Xiao-Ying Cha
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

5.  Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases.

Authors:  Asiye Safak Bulut; Esra Erden; Serpil Dizbay Sak; Hatice Doruk; Nazmiye Kursun; Dilek Dincol
Journal:  Virchows Arch       Date:  2005-06-10       Impact factor: 4.064

Review 6.  Redox Regulation of Inflammatory Processes Is Enzymatically Controlled.

Authors:  Inken Lorenzen; Lisa Mullen; Sander Bekeschus; Eva-Maria Hanschmann
Journal:  Oxid Med Cell Longev       Date:  2017-10-08       Impact factor: 6.543

7.  Prognostic Value of Inducible Nitric Oxide Synthase (iNOS) in Human Cancer: A Systematic Review and Meta-Analysis.

Authors:  Wenbiao Liao; Tao Ye; Haoran Liu
Journal:  Biomed Res Int       Date:  2019-06-04       Impact factor: 3.411

8.  Macrophage-tumor cell interactions regulate the function of nitric oxide.

Authors:  Michal A Rahat; Bernhard Hemmerlein
Journal:  Front Physiol       Date:  2013-06-18       Impact factor: 4.566

9.  Downregulation of Nitric Oxide Collaborated with Radiotherapy to Promote Anti-Tumor Immune Response via Inducing CD8+ T Cell Infiltration.

Authors:  Jieyu Xu; Yuan Luo; Cheng Yuan; Linzhi Han; Qiuji Wu; Liexi Xu; Yuke Gao; Yingming Sun; Shijing Ma; Guiliang Tang; Shuying Li; Wenjie Sun; Yan Gong; Conghua Xie
Journal:  Int J Biol Sci       Date:  2020-03-05       Impact factor: 6.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.